PP33 The Cost-effectiveness Of Regorafenib In The Treatment Of Advanced Hepatocellular Carcinoma From A Canadian Perspective
- Mohammad Salman Hussain
- , Ambrish Singh
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.